Condition: Immunization · HPV Infection · Human Papillomavirus · Sponsor: The University of Texas Medical Branch, Galveston
The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples over a period of 12 months. All 2-dose participants will be offered a 3rd dose after the final blood draw,12 months after their initial vaccination.
This description comes directly from the study's public registry record.
Abbey B Berenson, MD, PhD · 409-772-2417 · abberens@utmb.edu
Rosalina M Trujillo · 409-747-5594 · rmtrujil@utmb.edu
Always discuss trial participation with your own doctor first.
| University of Texas Medical Branch | Galveston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05672927